DOI: 10.5061/dryad.hqbzkh1df
title: The effect of an end-effector type of robot-assisted gait training on patients with Guillain-Barré syndrome

description: Background: Guillain-Barre syndrome (GBS) is a peripheral nerve injury
 caused by a post-infectious immune response. Although the prognosis of GBS
 is relatively good, some patients have severe impairments such as
 walking disabilities. Robot-assisted gait training (RAGT) is used to
 improve gait function in various neurologic disorders; however, no studies
 have reported its effectiveness in GBS patients. We aimed to evaluate the
 effect of gait training using an end-effector type robotic device on GBS
 patients. Methods: This was a retrospective study of patients diagnosed
 with GBS who received RAGT using Morning Walk® at the inpatient
 department. The main outcome measures evaluated before and after RAGT
 were: Medical Research Council scale, Functional Ambulation Categories,
 Modified Barthel Index score, Rivermead Mobility Index, and 2-minute walk
 test. Results: In total, 15 patients underwent RAGT 24 times. The mean age
 was 55.7 (±15.3) years and the average time from onset was 3.9 (±3.6)
 months. When compared to the baseline, all outcome measures associated
 with gait function were improved after RAGT. Conclusions: RAGT can improve
 walking ability in GBS patients. RAGT can be considered as one of the gait
 training tools to recover gait function in GBS patients.
description: We retrospectively analysed patients with GBS who treated robotic
 assisted gait training from April 2016 to January 2020. 
description: 1. Title of Dataset: The effect of an end-effector type of
 robot-assisted gait training on patients with Guillain-Barre
 syndrome 2. File List: RAGT in GBS
 3. Number of variables: 23 4. Number of
 cases/rows: 15 5. Variable List: <br>  age:
 years<br>  gender: 1(male), 2(female)<br>  onset: period from
 the datd of disease onset to the start of treatment<br>  hipFlx:
 muscle strength when flexing the hip joint before treatment<br>  
  0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)<br>
  FUhipFlx: muscle strength when flexing the hip joint after
 treatment<br>    0(zero), 1(trace), 2(poor), 3(fair), 4(good),
 5(normal)<br>  hipExt: muscle strength when extending the hip joint
 before treatment<br>    0(zero), 1(trace), 2(poor), 3(fair),
 4(good), 5(normal)<br>  FUhipExt: muscle strength when extending the
 hip joint after treatment<br>    0(zero), 1(trace), 2(poor),
 3(fair), 4(good), 5(normal)<br>  kneeFlx: muscle strength when
 flexing the knee joint before treatment<br>    0(zero), 1(trace),
 2(poor), 3(fair), 4(good), 5(normal)<br>  FUkneeFlx: muscle strength
 when flexing the knee joint after treatment<br>    0(zero),
 1(trace), 2(poor), 3(fair), 4(good), 5(normal)<br>  kneeExt: muscle
 strength when extending the knee joint before treatment<br>  
  0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)<br>
  FUkneeExt: muscle strength when extending the knee joint after
 treatment<br>    0(zero), 1(trace), 2(poor), 3(fair), 4(good),
 5(normal)<br>  ankleFlx: muscle strength when flexing the ankle
 joint before treatment<br>    0(zero), 1(trace), 2(poor), 3(fair),
 4(good), 5(normal)<br>  FUankleFlx: muscle strength when flexing the
 ankle joint after treatment<br>    0(zero), 1(trace), 2(poor),
 3(fair), 4(good), 5(normal)<br>  ankleExt: muscle strength when
 extending the ankle joint before treatment<br>    0(zero), 1(trace),
 2(poor), 3(fair), 4(good), 5(normal)<br>  FUankleExt: muscle
 strength when extending the ankle joint after treatment<br>  
  0(zero), 1(trace), 2(poor), 3(fair), 4(good), 5(normal)<br>  FAC:
 Functional Ambulation Category before treatment<br>  MBI: Modified
 Barthel Index before treatment<br>  TowMin: walking distance for 2
 minuites before treatment (units are meter)<br>  MI: Rivermead
 Mobility Index before treatment<br>  fuFAC: Functional Ambulation
 Category after treatment<br>  fuMBI: Modified Barthel Index after
 treatment<br>  fuTowMin: walking distance for 2 minuites after
 treatment<br>  fuMI: Rivermead Mobility Index after
 treatment